This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LEIOMYOSARCOMA_EXALLC for full statistics.
Leiomyosarcoma
C3_LEIOMYOSARCOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
237 |
4. Check minimum number of eventsNone |
237 |
5. Include endpointsNone |
237 |
6. Filter based on genotype QC (FinnGen only) |
237 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Leiomyosarcoma
based on the number of shared cases.
Similar with more cases:
- Leiomyosarcoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 237 | 160 | 77 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.03 |
| Median age at first event (years) | 59.86 | 57.17 | 65.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 218
- Matched controls
- 2177
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
74.3
67
*
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
40.9
38
*
128
Kela drug reimbursment
Cancers of female genital organs
36.3
34.6
44
15
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
34.3
32
*
H02AB02
ATC
dexamethasone; systemic
8.8
33.7
81
137
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
31.0
29
*
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
348.0
30.6
30
*
130
Kela drug reimbursment
Malignant tumour
9.2
30.0
68
102
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
14.7
28.5
49
42
159
Kela drug reimbursment
Pazopanib
293.6
26.3
26
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
25.5
24
*
JN4BD
NOMESCO Finland
Extensive body CT
6.7
24.8
71
147
L03AA13
ATC
pegfilgrastim; parenteral
13.2
24.5
44
41
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
24.4
23
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.8
23.5
101
333
A04AA01
ATC
ondansetron; systemic, rectal
7.9
22.2
54
87
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
14.1
22.1
38
32
B01AB10
ATC
tinzaparin; parenteral
8.2
22.0
52
80
N02AA05
ATC
oxycodone; systemic
5.1
22.0
82
230
TPX10
NOMESCO Finland
Implantation of vascular injection port
17.3
21.5
34
23
L01XE11
ATC
[U] pazopanib; oral
+∞
21.2
20
*
Z51.5
ICD-10 Finland
Palliative care
8.5
20.6
47
68
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
219.1
19.9
20
*
LCD00
NOMESCO Finland
Hysterectomy
10.5
19.1
38
43
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.0
18.4
40
53
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
16.9
16
*
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
16.9
16
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
16.0
16.8
27
19
B01AB05
ATC
enoxaparin; parenteral
3.5
16.7
110
490
JN4AD
NOMESCO Finland
Body CT examination
5.7
16.3
50
108
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.6
16.2
39
61
L03AA02
ATC
filgrastim; parenteral
11.4
16.0
30
30
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
16.4
15.8
25
17
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
86.0
14.8
16
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
14.7
14
*
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
5.8
14.2
42
86
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
57.2
14.0
16
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.1
13.9
39
75
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
8.5
13.7
30
40
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
36.7
13.7
17
5
L03AA14
ATC
lipegfilgrastim; parenteral
14.2
13.2
22
17
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
14.2
13.2
22
17
WF049
NOMESCO Finland
Radiotherapy of metastasis
8.4
13.2
29
39
XX3DW
NOMESCO Finland
Time consuming IT work
4.3
13.1
52
147
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.3
13.1
21
15
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.5
13.0
40
86
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
18.8
12.8
19
11
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
12.7
101
489
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
12.6
12
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
12.6
12
*
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
12.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.4
12.6
30
46
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.5
12.2
20
15
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
13.6
11.9
20
16
A04AD12
ATC
aprepitant; systemic
10.4
11.0
21
22
WF003
NOMESCO Finland
Adjuvant radiotherapy
7.7
10.9
25
36
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
63.2
10.7
12
*
A04AA02
ATC
granisetron; systemic, transdermal
5.3
10.7
33
71
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
10.5
10
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
10.5
10
*
JN4CD
NOMESCO Finland
Very extensive body CT
7.6
10.4
24
35
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
12.1
10.3
18
16
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
7.4
10.2
24
36
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
42.1
10.1
12
*
WF001
NOMESCO Finland
Preoperative radiotherapy
42.1
10.1
12
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
10.0
32
72
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
9.9
120
709
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
6.1
9.7
26
47
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
31.6
9.5
12
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
104.4
9.5
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
9.5
81
393
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
9.4
9
*
343
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
WW500
NOMESCO Finland
Blood transfusion
6.8
9.4
23
37
WZC30
NOMESCO Finland
Teaching
3.2
8.8
50
187
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
9.1
8.5
17
20
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
8.4
8
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
8.3
27
62
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
8.2
49
189
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
11.4
7.9
14
13
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
46.7
7.8
9
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
82.8
7.5
8
*
B02AA02
ATC
tranexamic acid; systemic
3.1
7.4
43
162
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
7.3
7
*
C49.83
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue leiomyosarcoma
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.3
7.3
26
66
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
8.4
7.2
15
19
ZZR00
NOMESCO Finland
Flap of skin
7.1
7.0
16
24
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
9.8
6.9
13
14
R50.9
ICD-10 Finland
Fever, unspecified
2.9
6.9
45
181
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.5
6.9
32
103
A79
ICPC
Malignancy NOS
9.1
6.7
13
15
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
71.9
6.5
7
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
71.9
6.5
7
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
14.9
6.5
10
7
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
6.4
36
133
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
18.7
6.3
9
5
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.7
6.3
17
32
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
6.3
6
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
6.3
6
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
6.3
6
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
27.5
6.3
8
*
JAH00
NOMESCO Finland
Laparotomy
5.9
6.1
16
29
C03CA01
ATC
furosemide; systemic
2.1
6.0
85
507
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
74
188
5.27
28.67
1.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
119
554
3.31
18.34
6.6
4.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
59
5.68
15.02
2.5
2.1
u/ml
0.4
0.3
0.21
16
31
(3044640) Blood type and Crossmatch panel - Blood
125
655
2.92
14.81
3.6
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
171
1117
2.91
12.47
21.4
9.6
e9/l
4.1
4.1
0.08
157
989
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
150
917
2.73
12.46
6.0
4.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
143
892
2.52
10.80
8.1
4.4
g/l
34.0
35.1
1.27
136
833
(3017181) Myelocytes/100 leukocytes in Blood
46
164
3.24
10.42
3.4
4.1
%
1.7
0.8
1.22
26
56
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
153
1018
2.42
9.54
8.4
7.1
mmol/l
1.2
1.2
0.69
124
865
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
145
947
2.37
9.37
8.1
6.1
mmol/l
1.2
1.2
0.41
137
858
(3021440) Promyelocytes/100 leukocytes in Blood
42
151
3.17
9.34
3.6
4.3
%
0.3
0.2
0.38
23
50
(3032080) INR in Blood by Coagulation assay
134
850
2.33
9.22
13.2
9.3
inr
1.3
1.3
0.33
42
238
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
92
501
2.37
9.00
3.3
2.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
40
146
3.09
8.65
3.4
4.1
%
1.3
0.5
1.58
20
39
(3002256) Pathology report gross observation
57
255
2.63
8.45
1.4
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
123
795
2.14
7.59
2.7
2.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
55
4.09
7.43
1.8
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
62
307
2.38
7.33
5.0
1.8
s
30.8
29.5
0.65
62
299
(3014007) Fractional oxyhemoglobin in Arterial blood
35
131
2.96
7.21
7.7
8.6
%
95.5
94.0
1.43
35
131
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
144
2.86
7.11
1.9
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
140
2.85
6.92
3.8
4.3
%
0.1
0.2
0.23
20
41
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
62
324
2.24
6.39
2.2
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
48
227
2.40
6.22
1.7
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
216
2.40
6.05
6.5
3.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
32
4.59
5.85
4.1
3.9
%
56.8
63.9
0.69
14
32
(3031040) Bacteria [#/volume] in Urine by Automated count
171
1321
2.06
5.80
6.1
4.7
e6/l
196.0
573.8
—
7
25
(42870588) Differential panel, method unspecified - Blood
99
639
1.94
5.69
6.5
5.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
17
6.10
5.67
1.7
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
45
217
2.33
5.56
1.8
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
413
2.03
5.46
6.9
3.1
mmol/l
2.5
2.5
0.09
64
361
(3000850) Epithelial cells [#/volume] in Urine
73
430
2.01
5.42
2.6
2.6
e6/l
7.6
5.5
0.56
63
381
(3003396) Base excess in Arterial blood by calculation
48
242
2.23
5.33
5.9
9.0
mmol/l
0.3
1.5
1.56
33
191
(3026008) Bacteria identified in Urine by Culture
99
655
1.88
5.17
3.5
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
107
726
1.86
5.16
3.8
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
31
4.38
5.16
4.0
3.0
e9/l
3.3
5.6
1.56
13
31
(3042936) Bacteria identified in Isolate by Culture
55
298
2.10
5.09
2.2
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
97
641
1.87
5.06
6.9
3.7
ph
7.4
7.4
0.06
28
118
(3019069) Monocytes/100 leukocytes in Blood
126
907
1.83
4.97
7.1
6.0
%
8.9
8.7
0.26
118
850
(3020891) Body temperature
23
84
2.92
4.94
4.7
4.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
222
2.21
4.86
1.9
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
127
923
1.81
4.79
7.1
5.9
%
23.1
27.4
3.75
117
858
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
46
239
2.15
4.72
2.3
4.8
ug/l
2.6
25.2
0.71
34
201
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
29
4.31
4.68
1.8
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
121
873
1.79
4.63
7.1
5.7
%
0.6
0.7
1.15
112
809
(40758558) Short blood count panel - Blood
80
514
1.84
4.46
19.1
6.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
45
3.49
4.40
4.4
2.7
mmol/l
2.5
2.1
—
10
28
(3018010) Neutrophils/100 leukocytes in Blood
124
911
1.76
4.37
6.5
5.6
%
60.3
57.6
1.26
114
855
(3015377) Calcium [Moles/volume] in Serum or Plasma
104
727
1.77
4.36
10.2
3.4
mmol/l
2.3
2.4
0.32
96
630
(3000991) Gas panel - Venous blood
34
161
2.30
4.36
8.2
8.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
92
621
1.79
4.34
6.7
2.9
u/l
46.2
33.0
0.86
86
597
(3006504) Eosinophils/100 leukocytes in Blood
123
903
1.75
4.34
7.0
5.6
%
2.4
2.7
1.03
113
841
(3001604) Monocytes [#/volume] in Blood
128
951
1.75
4.32
6.5
5.5
e9/l
0.6
0.6
0.63
116
826
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
31
4.02
4.31
1.4
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
31
4.02
4.31
1.4
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
131
983
1.74
4.24
6.6
5.8
e9/l
0.1
0.2
2.71
118
871
(3006315) Basophils [#/volume] in Blood
128
955
1.74
4.23
6.5
5.5
e9/l
0.0
0.0
0.64
116
831
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
27
4.22
4.21
1.5
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
23
4.50
4.13
1.7
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
91
620
1.76
4.12
3.8
3.2
e6/l
109.2
153.0
0.14
77
470
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
185
1545
1.90
4.06
19.6
7.6
u/l
94.2
79.2
3.73
179
1444
(3018095) Leukocytes [#/volume] in Urine
102
721
1.73
4.04
4.3
3.7
e6/l
432.8
94.2
0.52
82
505
(3030467) Casts [#/volume] in Urine by Automated count
84
566
1.75
3.92
3.6
3.0
e6/l
0.6
0.6
0.04
70
419
(3026782) Osmolality of Urine
66
414
1.82
3.92
3.0
2.8
mosm/kgh2o
495.1
536.9
0.74
56
354
(3002173) Hemoglobin [Mass/volume] in Arterial blood
38
198
2.09
3.86
6.9
9.9
g/l
116.5
119.9
0.60
38
193
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
335
1.88
3.85
3.2
2.6
e6/l
1.1
1.2
0.05
37
181
(36304419) Bacteria [Presence] in Urine
81
546
1.73
3.75
3.5
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
128
977
1.67
3.72
6.7
5.5
e9/l
1.8
2.0
0.30
117
868
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
35
3.56
3.67
1.4
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
13
6.33
3.53
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
170
2.09
3.45
2.4
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
42
3.22
3.42
1.6
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
52
315
1.83
3.42
3.6
2.9
e6/l
4.7
2.6
0.70
32
164
(4281824)
9
19
4.88
3.27
1.1
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
15
5.48
3.22
2.0
4.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
28
139
2.15
3.22
3.3
7.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
32
168
2.05
3.19
1.9
3.4
ng/l
158.7
170.9
0.08
25
151
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
120
2.21
3.12
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
7
12
5.97
3.04
1.1
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
12
5.97
3.04
1.6
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
5
10.17
2.99
1.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
52
2.80
2.94
1.6
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
62
412
1.68
2.94
5.6
4.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
88
641
1.59
2.90
2.9
3.2
ng/l
2749.0
1409.2
1.35
78
553
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
13
5.51
2.89
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
9
6.80
2.88
2.8
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
6
8.48
2.76
1.6
1.7
umol/l
2.4
1.6
—
5
6
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
100
2.21
2.68
8.5
13.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
55
2.64
2.67
1.6
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
187
1.89
2.66
3.7
3.5
mmol/l
1.7
2.4
0.44
26
151
(3012544) pH of Venous blood
34
197
1.85
2.56
3.7
3.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
327
0.45
2.51
1.4
1.3
u/ml
26.1
13.1
0.25
11
121
(3021589) Normoblasts [#/volume] in Blood
108
848
1.50
2.44
17.2
9.8
e9/l
0.0
0.0
0.59
92
692
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
34
539
0.57
2.42
1.6
1.6
mmol/l
1.3
1.3
0.23
25
456
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
17
4.21
2.38
2.9
1.5
ug/l
26.0
17.2
—
7
17
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
47
2.64
2.31
1.5
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
30
3.08
2.17
1.3
8.7
—
150.5
—
0
6
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
6
14
4.37
2.16
1.3
1.0
—
3.5
—
0
6
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
25
3.27
2.11
2.1
3.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
112
1.96
2.04
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
38
2.70
2.03
2.8
2.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
68
502
1.50
2.01
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
70
523
1.48
1.95
4.7
4.3
estimate
0.0
0.0
0.00
25
176
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
42
280
1.61
1.95
3.0
2.2
%
21.0
21.8
0.16
37
245
(3037467) Urinalysis macro (dipstick) panel - Urine
155
1346
1.44
1.89
5.5
4.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
114
940
1.41
1.85
4.2
3.9
estimate
0.0
0.0
0.00
28
180
(40768441) Liver Pathology biopsy report
6
17
3.59
1.85
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
117
1.87
1.81
2.5
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
18
3.39
1.76
3.2
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
18
3.39
1.76
1.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
115
956
1.39
1.75
4.3
3.9
estimate
0.0
0.0
0.00
26
175
(3021601) Nitrite [Presence] in Urine by Test strip
114
947
1.39
1.74
5.4
5.3
estimate
0.0
0.0
0.00
27
175
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
13
3.90
1.72
1.2
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
13
3.90
1.72
1.2
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
60
445
1.47
1.72
2.8
3.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
25
2.85
1.66
1.9
1.9
%
85.2
90.2
—
7
25
(3000494) Fungus identified in Specimen by Culture
36
241
1.58
1.65
1.3
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
63
476
1.44
1.64
2.0
2.2
mg/l
3.1
3.2
0.13
54
418
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
14
3.62
1.62
2.2
2.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
5
14
3.62
1.62
1.0
1.0
—
1.6
—
0
5
(3000492) Spirometry study
7
156
0.43
1.62
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
20
3.05
1.59
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
21
338
0.58
1.56
1.3
1.3
iu/ml
15.9
34.9
—
7
112
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
0
42
0.00
1.54
0.0
1.3
—
56.2
—
0
5
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
14
72
2.00
1.52
5.2
2.1
ug/l
504.0
886.7
0.26
14
66
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
206
1920
1.56
1.50
32.3
15.3
mg/l
31.3
22.8
2.72
193
1526
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
16
3.17
1.44
1.4
1.2
u/l
65.0
48.8
—
5
8
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
68
1.96
1.36
2.1
2.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
24
2.54
1.31
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
24
2.54
1.31
2.7
2.1
pg
34.2
33.2
—
6
24
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
51
389
1.40
1.25
4.0
4.0
ng/l
26.2
311.3
2.08
44
322
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
25
2.44
1.25
1.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
87
1.77
1.18
2.9
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
50
636
0.73
1.18
3.4
3.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
20
2.53
1.15
1.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
278
0.62
1.15
1.4
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
58
1.94
1.14
1.2
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
54
423
1.36
1.13
4.3
4.3
kg/l
1.0
1.0
—
7
64
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
193
1803
1.38
1.12
33.8
14.5
ml/min/173m2
76.4
76.5
0.03
181
1497
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
31
2.30
1.11
1.1
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
32
2.22
1.09
1.3
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
32
2.22
1.09
1.3
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
32
2.22
1.09
1.3
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
52
1.96
1.08
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
33
2.15
1.06
1.3
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
33
2.15
1.06
1.3
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
107
0.46
1.04
1.4
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
27
190
1.48
1.02
1.6
2.5
ug/l
13.7
7.0
0.28
21
167
(40761536) Microorganisms panel - Urine sediment
24
165
1.51
1.01
4.5
3.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
157
1.51
1.00
5.3
2.9
ml/min/173m2
56.9
59.3
0.12
12
63
(4306422)
5
23
2.20
0.98
2.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
183
1937
0.76
0.97
4.4
5.3
mmol/l
2.6
2.7
0.94
163
1775
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
27
2.25
0.94
1.3
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
28
2.17
0.92
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
63
1.78
0.91
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
134
1210
1.25
0.91
4.5
3.1
u/l
74.5
47.5
2.03
128
1119
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
29
2.10
0.90
1.5
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
29
2.10
0.90
12.7
7.4
mmol/l
7.1
6.6
—
6
23
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
29
2.10
0.90
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
731
1.25
0.89
5.0
4.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
64
1.75
0.87
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
64
1.75
0.87
1.1
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
30
2.03
0.87
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
27
197
1.42
0.87
4.8
4.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
94
821
1.24
0.85
4.3
4.0
ng/l
30.6
39.9
0.48
80
595
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
45
1.80
0.85
1.5
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
31
1.96
0.85
1.0
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
31
1.96
0.85
1.0
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
31
1.96
0.85
1.0
1.4
—
—
—
0
0
(4034850)
11
65
1.73
0.84
10.1
8.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
46
1.76
0.83
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
46
1.76
0.83
1.4
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
160
1482
1.25
0.83
4.7
4.1
pmol/l
14.9
14.9
0.06
150
1319
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
253
1.35
0.81
6.5
6.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
33
1.84
0.79
1.5
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
150
1385
1.23
0.77
4.6
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
14
91
1.57
0.77
4.1
4.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
28
0.00
0.76
0.0
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
134
0.58
0.76
2.4
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
54
1.69
0.75
1.2
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
1.0
1.1
pmol/l
422.8
264.1
—
5
19
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
179
1883
0.80
0.74
4.0
4.6
mmol/l
1.5
1.5
0.42
159
1729
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
25
2.02
0.73
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
18
250
0.70
0.72
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
58
1.57
0.70
1.1
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
41
1.73
0.70
1.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
43
1.65
0.67
4.6
3.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
181
1896
0.81
0.67
3.9
4.7
mmol/l
4.5
4.7
1.08
163
1748
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
62
1.64
0.66
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
71
809
0.83
0.66
2.4
2.2
nmol/l
75.5
78.8
0.52
63
719
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
104
1.47
0.64
3.3
2.4
%
1.2
1.2
0.10
15
104
(40761511) CBC panel - Blood by Automated count
205
1975
1.28
0.61
28.4
14.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
2.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
173
1814
0.83
0.60
6.2
6.1
mmol/mol
43.4
40.6
1.98
152
1683
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
51
433
1.23
0.59
1.9
1.7
mg/l
2.0
1.2
0.87
39
355
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
69
606
1.20
0.57
2.6
3.0
mmol/l
7.1
7.2
0.08
53
505
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
36
1.68
0.57
1.8
1.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
90
0.55
0.57
4.0
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
90
1.47
0.56
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
82
1.49
0.55
2.9
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
61
1.49
0.54
5.4
5.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
171
1.32
0.52
2.0
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
40
1.51
0.52
2.3
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
22
172
1.31
0.50
2.5
3.1
e9/l
59.9
71.6
0.75
16
140
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
108
0.64
0.50
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
177
0.72
0.49
1.8
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
117
0.67
0.47
1.5
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
19
148
1.31
0.45
2.6
2.8
g/l
8.4
10.2
1.91
19
136
(3012516) Albumin [Mass/volume] in Urine
66
590
1.16
0.45
2.7
3.1
mg/l
877.6
251.6
0.34
45
385
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
51
1.38
0.44
1.6
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
31
1.63
0.43
2.4
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
420
1.18
0.42
1.6
1.8
pmol/l
515.6
473.7
0.19
34
347
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
0
16
0.00
0.41
0.0
3.3
—
19.3
—
0
10
(3050129) First trimester maternal screen panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
36
418
0.84
0.41
2.0
1.7
nmol/l
1425.3
1206.7
0.62
23
318
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
270.4
—
0
9
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
448.1
—
0
10
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
17
0.00
0.41
0.0
1.2
—
7.1
—
0
12
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
40.6
—
0
9
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
36
1.40
0.38
2.2
2.6
mmol/l
3.8
4.1
—
5
36
(3035285) Chloride [Moles/volume] in Venous blood
5
36
1.40
0.38
2.2
2.6
mmol/l
103.8
106.4
—
5
36
(40768797) Stomach Pathology biopsy report
30
254
1.21
0.38
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.6
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
81
1.38
0.37
2.7
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
71
1.28
0.36
1.8
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
90
1.35
0.36
1.1
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
41
1.48
0.36
1.0
1.2
mmol/l
4.4
3.9
—
6
36
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
175
1809
0.88
0.36
3.8
4.2
mmol/l
1.3
1.3
0.65
154
1651
(3007930) Methemoglobin/Hemoglobin.total in Blood
10
74
1.37
0.33
3.1
11.3
%
0.8
0.9
—
10
69
(3041096) Erythrocytes [Presence] in Urine by Automated
57
518
1.13
0.31
5.2
3.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
7
54
1.31
0.30
3.0
15.1
mmol/l
0.9
1.2
—
7
48
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
75
1.35
0.30
3.1
11.2
%
1.6
1.6
—
10
70
(3028026) IgM [Mass/volume] in Serum or Plasma
15
121
1.26
0.29
2.2
1.6
g/l
0.7
1.4
2.02
15
111
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
57
1.23
0.29
2.6
2.0
mmol/l
25.4
25.1
—
7
45
(21494755) Public health laboratory ask at order entry panel
9
116
0.77
0.28
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
104
1.26
0.27
2.1
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
23
266
0.85
0.26
3.7
4.7
%
33.2
31.5
0.31
17
176
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
23
198
1.18
0.26
1.9
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
133
1.22
0.25
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
98
1028
0.92
0.23
2.6
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
41
1.22
0.22
2.6
2.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
55
511
1.10
0.21
2.6
2.7
umol/l
342.7
7983.2
2.65
47
435
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
12
0.00
0.21
0.0
1.5
—
4.8
—
0
7
(3051593) INR in Capillary blood by Coagulation assay
0
12
0.00
0.21
0.0
13.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
12
0.00
0.21
0.0
2.2
—
13.6
—
0
12
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
43
1.17
0.21
1.0
1.3
iu/l
60.4
29.3
—
5
36
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
0.9
—
0
13
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
8.5
—
0.7
—
0
13
(3004588) Protein electrophoresis panel - Serum or Plasma
13
155
0.83
0.21
2.5
2.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
108
1.22
0.20
4.5
4.0
—
—
—
0
0
(3013512) EKG study
66
621
1.09
0.20
5.3
4.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
62
1.13
0.17
1.9
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
68
1.18
0.17
1.8
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
185
1882
0.92
0.16
4.4
4.9
mmol/l
6.2
6.0
0.75
165
1722
(3022621) pH of Urine by Test strip
12
140
0.85
0.15
3.2
2.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
500
1.08
0.15
1.5
1.5
nmol/l
22.3
21.1
0.27
46
418
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
87
0.80
0.15
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
95
1.17
0.12
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
291
0.92
0.11
3.4
3.2
ug/l
0.7
0.8
0.31
22
200
(40760888) Immunoglobulin light chains.free panel - Serum
5
45
1.11
0.10
4.2
5.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
165
1671
0.96
0.08
31.7
16.3
%
37.4
39.3
2.16
108
1161
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
128
1.10
0.07
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
92
0.87
0.07
1.8
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
9
100
0.90
0.06
1.1
1.2
u/ml
124.9
175.3
—
9
92
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
40
386
1.04
0.05
6.0
4.7
%
19.2
21.4
0.59
25
205
(46235355) HIV 1 and 2 tests - Meaningful Use set
23
241
0.95
0.04
1.9
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
28
269
1.05
0.04
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
111
1.09
0.04
2.2
2.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
64
628
1.03
0.03
3.6
3.8
mg/mmol
8.7
7.3
0.18
42
386
(4010399)
16
151
1.06
0.03
1.2
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
80
789
1.02
0.03
2.9
2.7
ug/l
179.3
118.5
1.57
75
723
(3013707) Erythrocyte sedimentation rate by Westergren method
147
1479
0.98
0.02
3.7
4.1
mm/h
17.7
13.3
1.44
126
1351
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
82
828
0.99
0.01
1.9
2.0
pmol/l
91.6
95.4
0.28
46
406
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
104
1.06
0.01
3.3
3.5
pmol/l
4.3
4.5
0.40
11
90
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
180
1794
1.01
0.00
5.3
4.9
mu/l
2.1
2.6
0.34
165
1618
(3007164) IgA [Mass/volume] in Serum or Plasma
37
374
0.99
0.00
1.7
1.4
g/l
2.8
2.5
0.17
20
225
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
41
405
1.01
0.00
1.2
1.2
u/ml
1.0
1.6
0.61
14
119
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
92.2
—
0
9
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
15.4
—
1221.9
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
28.2
—
0
9
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
17.8
—
2231.9
—
0
9
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
49
1.02
0.00
1.4
2.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
6.7
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
57
0.87
0.00
1.4
3.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
87
0.92
0.00
1.5
2.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
5
51
0.98
0.00
2.6
2.1
kpa
7.4
7.7
—
5
45
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
15.4
—
0
5
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
2.0
—
70.4
—
0
8
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
64
0.94
0.00
7.0
4.2
—
3.2
—
0
8
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
8.5
—
23.8
—
0
6
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.1
—
8.7
—
0
8
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
9.6
—
0
8
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LEIOMYOSARCOMA – Leiomyosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).